Navigation Links
New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse

New research appearing in the December 29 issue of the New England Journal of Medicine says that a new drug called as Femara is better than tamoxifen fro preventing the chances // of a relapse of breast cancer. Femara is a drug manufactured by Novartis AG and is chemically letrozole.

This belongs to a class of drugs called as the aromatase inhibitors of which Arimidex is also a part. In the current study, which was co-ordinated by the Senology Center of Eastern Switzerland in Kantonsspital, 8,000 women were assessed after taking either tamoxifen or Femara. It was found that Femara reduced the chances of breast cancer relapse by 29 percent over what tamoxifen achieved. In addition to this, Femara also conferred a 27 percent less chance of metastasis of the cancer to other parts of the body. Tamoxifen is regarded as the "gold standard" in treatment of breast cancer, but this new class of drugs is demonstrating better results in hormone-sensitive breast cancer. This is especially true in post-menopausal women, who are more prone to develop estrogen-related breast cancer. Femara works by reducing the levels of this hormone, which is essential to trigger the growth of tumors, whereas tamoxifen prevents the entry of estrogen into cancer cells. . "Five years of treatment with tamoxifen reduces the risk of breast cancer recurrence by 47% and the risk of death by 26%," wrote Dr. Beat Thurlimann and colleagues. "Despite these benefits, about half the women so treated relapse."

Femara has now been approved by the U.S. Food and Drug Administration fro use in post-menopausal women who have undergone surgery for hormone-sensitive early-stage breast cancer.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today ... Inc.,s Supplier Horizon Award . One ... Guerbet was recognized for its support of Premier members ... through clinical excellence, and commitment to lower costs. ... receive this recognition of our outstanding customer service from ...
(Date:6/23/2016)... The Biotechnology industry might still ... great opportunities to investors. Stock-Callers.com assesses the recent performances ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... your complimentary trade alerts at: http://stock-callers.com/registration ...
Breaking Medicine Technology: